Abstract
MHC-II expression on cancer cells is associated with improved treatment outcome. In this issue, Huang etal.1 report a panel of small molecules that selectively upregulate MHC-II on cancer cells through suppression of fatty acid synthase (FASN), resulting in inhibition of tumor growth. Targeting this link between lipid metabolism and antigen presentation may improve response to immunotherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have